nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—muscle cancer	0.532	1	CbGaD
Bumetanide—SLC22A11—Methotrexate—muscle cancer	0.0754	0.225	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—muscle cancer	0.0718	0.215	CbGbCtD
Bumetanide—PTGS2—Etoposide—muscle cancer	0.0624	0.187	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—muscle cancer	0.0503	0.151	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—muscle cancer	0.0438	0.131	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—muscle cancer	0.0305	0.0913	CbGbCtD
Bumetanide—SLC12A1—appendage—muscle cancer	0.00709	0.0835	CbGeAlD
Bumetanide—SLC12A4—embryo—muscle cancer	0.00407	0.048	CbGeAlD
Bumetanide—Hypochloraemia—Doxorubicin—muscle cancer	0.0028	0.0575	CcSEcCtD
Bumetanide—PTGS2—hindlimb—muscle cancer	0.00272	0.0321	CbGeAlD
Bumetanide—SLC12A5—head—muscle cancer	0.00248	0.0292	CbGeAlD
Bumetanide—CFTR—renal system—muscle cancer	0.00242	0.0285	CbGeAlD
Bumetanide—SLC12A5—testis—muscle cancer	0.0024	0.0282	CbGeAlD
Bumetanide—CA7—renal system—muscle cancer	0.00238	0.0281	CbGeAlD
Bumetanide—PTGS2—appendage—muscle cancer	0.00234	0.0275	CbGeAlD
Bumetanide—SLC12A2—renal system—muscle cancer	0.00213	0.025	CbGeAlD
Bumetanide—SLC12A4—head—muscle cancer	0.00206	0.0243	CbGeAlD
Bumetanide—SLC10A1—renal system—muscle cancer	0.00201	0.0237	CbGeAlD
Bumetanide—SLC12A4—testis—muscle cancer	0.00199	0.0235	CbGeAlD
Bumetanide—Azotaemia—Vincristine—muscle cancer	0.00194	0.0398	CcSEcCtD
Bumetanide—SLC12A2—cardiac atrium—muscle cancer	0.0019	0.0224	CbGeAlD
Bumetanide—SLC22A11—renal system—muscle cancer	0.00183	0.0216	CbGeAlD
Bumetanide—SLC22A7—renal system—muscle cancer	0.00179	0.0211	CbGeAlD
Bumetanide—SLC12A1—renal system—muscle cancer	0.00178	0.021	CbGeAlD
Bumetanide—CA14—cardiac atrium—muscle cancer	0.00178	0.0209	CbGeAlD
Bumetanide—SLC12A2—tendon—muscle cancer	0.00166	0.0196	CbGeAlD
Bumetanide—CA9—tendon—muscle cancer	0.00163	0.0192	CbGeAlD
Bumetanide—CFTR—head—muscle cancer	0.00162	0.0191	CbGeAlD
Bumetanide—SLC12A2—bone marrow—muscle cancer	0.00161	0.0189	CbGeAlD
Bumetanide—CFTR—testis—muscle cancer	0.00156	0.0184	CbGeAlD
Bumetanide—CA14—tendon—muscle cancer	0.00155	0.0183	CbGeAlD
Bumetanide—CA12—renal system—muscle cancer	0.00155	0.0182	CbGeAlD
Bumetanide—SLC12A2—vagina—muscle cancer	0.00154	0.0181	CbGeAlD
Bumetanide—SLC12A2—head—muscle cancer	0.00142	0.0168	CbGeAlD
Bumetanide—SLC12A2—testis—muscle cancer	0.00137	0.0162	CbGeAlD
Bumetanide—CA9—testis—muscle cancer	0.00135	0.0159	CbGeAlD
Bumetanide—SLC10A1—head—muscle cancer	0.00134	0.0158	CbGeAlD
Bumetanide—SLC10A1—testis—muscle cancer	0.0013	0.0153	CbGeAlD
Bumetanide—CA5B—cardiac atrium—muscle cancer	0.00124	0.0147	CbGeAlD
Bumetanide—SLC12A1—head—muscle cancer	0.00119	0.014	CbGeAlD
Bumetanide—SLC22A7—testis—muscle cancer	0.00116	0.0136	CbGeAlD
Bumetanide—SLC12A1—testis—muscle cancer	0.00115	0.0136	CbGeAlD
Bumetanide—Hyperuricaemia—Vincristine—muscle cancer	0.00111	0.0228	CcSEcCtD
Bumetanide—CA5B—tendon—muscle cancer	0.00108	0.0128	CbGeAlD
Bumetanide—SLCO1A2—renal system—muscle cancer	0.00108	0.0128	CbGeAlD
Bumetanide—Blood uric acid increased—Vincristine—muscle cancer	0.00105	0.0216	CcSEcCtD
Bumetanide—Musculoskeletal pain—Vincristine—muscle cancer	0.00104	0.0214	CcSEcCtD
Bumetanide—CA12—head—muscle cancer	0.00104	0.0122	CbGeAlD
Bumetanide—SLC22A8—renal system—muscle cancer	0.00103	0.0122	CbGeAlD
Bumetanide—CA5B—vagina—muscle cancer	0.00101	0.0119	CbGeAlD
Bumetanide—CA4—renal system—muscle cancer	0.000959	0.0113	CbGeAlD
Bumetanide—Azotaemia—Methotrexate—muscle cancer	0.000939	0.0193	CcSEcCtD
Bumetanide—CA5B—head—muscle cancer	0.00093	0.0109	CbGeAlD
Bumetanide—Hyperuricaemia—Etoposide—muscle cancer	0.0009	0.0185	CcSEcCtD
Bumetanide—CA5B—testis—muscle cancer	0.000898	0.0106	CbGeAlD
Bumetanide—CA4—cardiac atrium—muscle cancer	0.000859	0.0101	CbGeAlD
Bumetanide—Polyuria—Vincristine—muscle cancer	0.000852	0.0175	CcSEcCtD
Bumetanide—Blood uric acid increased—Etoposide—muscle cancer	0.000851	0.0175	CcSEcCtD
Bumetanide—Encephalopathy—Methotrexate—muscle cancer	0.000779	0.016	CcSEcCtD
Bumetanide—PTGS2—embryo—muscle cancer	0.000776	0.00914	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.000754	0.0155	CcSEcCtD
Bumetanide—Hyponatraemia—Vincristine—muscle cancer	0.000752	0.0154	CcSEcCtD
Bumetanide—CA4—tendon—muscle cancer	0.000749	0.00882	CbGeAlD
Bumetanide—SLCO1A2—head—muscle cancer	0.000725	0.00854	CbGeAlD
Bumetanide—CA4—bone marrow—muscle cancer	0.000725	0.00854	CbGeAlD
Bumetanide—Serum creatinine increased—Doxorubicin—muscle cancer	0.000704	0.0145	CcSEcCtD
Bumetanide—SLCO1A2—testis—muscle cancer	0.000701	0.00825	CbGeAlD
Bumetanide—Dehydration—Vincristine—muscle cancer	0.000696	0.0143	CcSEcCtD
Bumetanide—SLC22A8—head—muscle cancer	0.000692	0.00816	CbGeAlD
Bumetanide—CA4—head—muscle cancer	0.000642	0.00756	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00064	0.0131	CcSEcCtD
Bumetanide—Hyperventilation—Doxorubicin—muscle cancer	0.00063	0.0129	CcSEcCtD
Bumetanide—CA4—testis—muscle cancer	0.00062	0.0073	CbGeAlD
Bumetanide—PTGS2—smooth muscle tissue—muscle cancer	0.00061	0.00718	CbGeAlD
Bumetanide—PTGS2—renal system—muscle cancer	0.000587	0.00691	CbGeAlD
Bumetanide—Sweating—Vincristine—muscle cancer	0.000553	0.0114	CcSEcCtD
Bumetanide—Erythema multiforme—Dactinomycin—muscle cancer	0.000548	0.0113	CcSEcCtD
Bumetanide—Cramp muscle—Etoposide—muscle cancer	0.000546	0.0112	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000546	0.0112	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—muscle cancer	0.000539	0.0111	CcSEcCtD
Bumetanide—Glycosuria—Doxorubicin—muscle cancer	0.000535	0.011	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—muscle cancer	0.000519	0.0107	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—muscle cancer	0.000515	0.0106	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—muscle cancer	0.00051	0.0105	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—muscle cancer	0.000467	0.00959	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000463	0.00952	CcSEcCtD
Bumetanide—Renal failure—Etoposide—muscle cancer	0.000459	0.00943	CcSEcCtD
Bumetanide—PTGS2—tendon—muscle cancer	0.000458	0.0054	CbGeAlD
Bumetanide—Leukopenia—Dactinomycin—muscle cancer	0.000452	0.00928	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—muscle cancer	0.000448	0.0092	CcSEcCtD
Bumetanide—PTGS2—bone marrow—muscle cancer	0.000444	0.00523	CbGeAlD
Bumetanide—Blood uric acid increased—Doxorubicin—muscle cancer	0.000441	0.00906	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000439	0.00901	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—muscle cancer	0.000433	0.0089	CcSEcCtD
Bumetanide—PTGS2—vagina—muscle cancer	0.000425	0.00501	CbGeAlD
Bumetanide—Polyuria—Methotrexate—muscle cancer	0.000414	0.0085	CcSEcCtD
Bumetanide—Vertigo—Vincristine—muscle cancer	0.000405	0.00832	CcSEcCtD
Bumetanide—Leukopenia—Vincristine—muscle cancer	0.000404	0.00829	CcSEcCtD
Bumetanide—Thrombocytopenia—Dactinomycin—muscle cancer	0.000403	0.00828	CcSEcCtD
Bumetanide—Erythema multiforme—Etoposide—muscle cancer	0.000397	0.00815	CcSEcCtD
Bumetanide—PTGS2—head—muscle cancer	0.000393	0.00463	CbGeAlD
Bumetanide—Thrombocytopenia—Vincristine—muscle cancer	0.00036	0.0074	CcSEcCtD
Bumetanide—Hyperhidrosis—Vincristine—muscle cancer	0.000356	0.00731	CcSEcCtD
Bumetanide—Fatigue—Dactinomycin—muscle cancer	0.000355	0.00729	CcSEcCtD
Bumetanide—Muscle spasms—Etoposide—muscle cancer	0.000351	0.00721	CcSEcCtD
Bumetanide—Hypotension—Vincristine—muscle cancer	0.000344	0.00706	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000337	0.00692	CcSEcCtD
Bumetanide—Vertigo—Etoposide—muscle cancer	0.000328	0.00674	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000327	0.00672	CcSEcCtD
Bumetanide—Leukopenia—Etoposide—muscle cancer	0.000327	0.00671	CcSEcCtD
Bumetanide—Abdominal pain—Dactinomycin—muscle cancer	0.000326	0.00669	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—muscle cancer	0.000324	1	CrCbGaD
Bumetanide—Fatigue—Vincristine—muscle cancer	0.000317	0.00652	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—muscle cancer	0.000316	0.00649	CcSEcCtD
Bumetanide—Chest pain—Etoposide—muscle cancer	0.000311	0.00639	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—muscle cancer	0.000308	0.00632	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—muscle cancer	0.000301	0.00618	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vincristine—muscle cancer	0.000301	0.00618	CcSEcCtD
Bumetanide—Asthenia—Dactinomycin—muscle cancer	0.000295	0.00607	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—muscle cancer	0.000295	0.00605	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—muscle cancer	0.000292	0.00601	CcSEcCtD
Bumetanide—Thrombocytopenia—Etoposide—muscle cancer	0.000292	0.00599	CcSEcCtD
Bumetanide—Abdominal pain—Vincristine—muscle cancer	0.000291	0.00597	CcSEcCtD
Bumetanide—Hyperhidrosis—Etoposide—muscle cancer	0.000288	0.00592	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—muscle cancer	0.000286	0.00588	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000283	0.00582	CcSEcCtD
Bumetanide—Diarrhoea—Dactinomycin—muscle cancer	0.000282	0.00579	CcSEcCtD
Bumetanide—Hypotension—Etoposide—muscle cancer	0.000278	0.00572	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000277	0.0057	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—muscle cancer	0.000275	0.00565	CcSEcCtD
Bumetanide—Sweating—Methotrexate—muscle cancer	0.000268	0.00551	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—muscle cancer	0.000267	0.00547	CcSEcCtD
Bumetanide—Asthenia—Vincristine—muscle cancer	0.000264	0.00542	CcSEcCtD
Bumetanide—Vomiting—Dactinomycin—muscle cancer	0.000262	0.00538	CcSEcCtD
Bumetanide—Rash—Dactinomycin—muscle cancer	0.00026	0.00533	CcSEcCtD
Bumetanide—Fatigue—Etoposide—muscle cancer	0.000257	0.00528	CcSEcCtD
Bumetanide—Diarrhoea—Vincristine—muscle cancer	0.000252	0.00517	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—muscle cancer	0.000245	0.00504	CcSEcCtD
Bumetanide—Nausea—Dactinomycin—muscle cancer	0.000245	0.00502	CcSEcCtD
Bumetanide—Gastrointestinal pain—Etoposide—muscle cancer	0.000244	0.00501	CcSEcCtD
Bumetanide—Dizziness—Vincristine—muscle cancer	0.000243	0.005	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00024	0.00494	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—muscle cancer	0.000238	0.00489	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—muscle cancer	0.000238	0.00488	CcSEcCtD
Bumetanide—Urticaria—Etoposide—muscle cancer	0.000237	0.00486	CcSEcCtD
Bumetanide—Abdominal pain—Etoposide—muscle cancer	0.000236	0.00484	CcSEcCtD
Bumetanide—Vomiting—Vincristine—muscle cancer	0.000234	0.0048	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—muscle cancer	0.000232	0.00477	CcSEcCtD
Bumetanide—Rash—Vincristine—muscle cancer	0.000232	0.00476	CcSEcCtD
Bumetanide—Dermatitis—Vincristine—muscle cancer	0.000232	0.00476	CcSEcCtD
Bumetanide—Headache—Vincristine—muscle cancer	0.00023	0.00473	CcSEcCtD
Bumetanide—Nausea—Vincristine—muscle cancer	0.000219	0.00449	CcSEcCtD
Bumetanide—Asthenia—Etoposide—muscle cancer	0.000214	0.00439	CcSEcCtD
Bumetanide—Pruritus—Etoposide—muscle cancer	0.000211	0.00433	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—muscle cancer	0.000206	0.00423	CcSEcCtD
Bumetanide—Diarrhoea—Etoposide—muscle cancer	0.000204	0.00419	CcSEcCtD
Bumetanide—Dizziness—Etoposide—muscle cancer	0.000197	0.00405	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—muscle cancer	0.000197	0.00404	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—muscle cancer	0.000196	0.00402	CcSEcCtD
Bumetanide—Vomiting—Etoposide—muscle cancer	0.000189	0.00389	CcSEcCtD
Bumetanide—Rash—Etoposide—muscle cancer	0.000188	0.00386	CcSEcCtD
Bumetanide—Dermatitis—Etoposide—muscle cancer	0.000188	0.00386	CcSEcCtD
Bumetanide—Headache—Etoposide—muscle cancer	0.000187	0.00383	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—muscle cancer	0.000186	0.00382	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—muscle cancer	0.000186	0.00382	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—muscle cancer	0.000182	0.00374	CcSEcCtD
Bumetanide—Nausea—Etoposide—muscle cancer	0.000177	0.00364	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—muscle cancer	0.000175	0.00359	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—muscle cancer	0.000173	0.00354	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—muscle cancer	0.00017	0.0035	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—muscle cancer	0.00017	0.00348	CcSEcCtD
Bumetanide—Hypotension—Methotrexate—muscle cancer	0.000167	0.00343	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—muscle cancer	0.000161	0.00331	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—muscle cancer	0.000161	0.00331	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—muscle cancer	0.000158	0.00324	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—muscle cancer	0.000154	0.00316	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—muscle cancer	0.000151	0.00311	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—muscle cancer	0.000149	0.00307	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—muscle cancer	0.000146	0.003	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—muscle cancer	0.000144	0.00297	CcSEcCtD
Bumetanide—Urticaria—Methotrexate—muscle cancer	0.000142	0.00291	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—muscle cancer	0.000141	0.0029	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—muscle cancer	0.000133	0.00274	CcSEcCtD
Bumetanide—Asthenia—Methotrexate—muscle cancer	0.000128	0.00263	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000126	0.0026	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—muscle cancer	0.000126	0.00259	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—muscle cancer	0.000123	0.00252	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—muscle cancer	0.000122	0.00251	CcSEcCtD
Bumetanide—Diarrhoea—Methotrexate—muscle cancer	0.000122	0.00251	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—muscle cancer	0.000118	0.00242	CcSEcCtD
Bumetanide—Vomiting—Methotrexate—muscle cancer	0.000114	0.00233	CcSEcCtD
Bumetanide—Rash—Methotrexate—muscle cancer	0.000113	0.00231	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—muscle cancer	0.000112	0.00231	CcSEcCtD
Bumetanide—Headache—Methotrexate—muscle cancer	0.000112	0.0023	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—muscle cancer	0.000111	0.00228	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—muscle cancer	0.000109	0.00225	CcSEcCtD
Bumetanide—Nausea—Methotrexate—muscle cancer	0.000106	0.00218	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—muscle cancer	0.000106	0.00217	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—muscle cancer	0.000102	0.0021	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—muscle cancer	9.83e-05	0.00202	CcSEcCtD
Bumetanide—Rash—Doxorubicin—muscle cancer	9.75e-05	0.002	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—muscle cancer	9.74e-05	0.002	CcSEcCtD
Bumetanide—Headache—Doxorubicin—muscle cancer	9.68e-05	0.00199	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—muscle cancer	9.18e-05	0.00189	CcSEcCtD
